Media

NANO: LATE-BREAKING ABSTRACT ON BETALUTIN® PHASE 1/2 STUDY ACCEPTED FOR PRESENTATION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2016

BONESUPPORT™ ANNOUNCES AVAILABILITY IN EUROPE OF CERAMENT™|G IN 5 mL VOLUME TO ADDRESS GROWING MARKET DEMAND

Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics

GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy

Nexstim Plc Receives Interim Analysis Information and Recommendation from DSMB for Phase III Stroke Therapy Trial

NORDIC NANOVECTOR ASA: FOURTH QUARTER AND FULL YEAR 2015 RESULTS; OPERATIONS ON TRACK

Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences

Cerenis Therapeutics featured prominently at the 25th Conference of the ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL)

Strongbridge Biopharma plc Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day